We are live on ! Find out more
CEMI

Chembio diagnostics, Inc.

Delisted

CEMI was delisted on the 27th of April, 2023.

36 hedge funds and large institutions have $2.33M invested in Chembio diagnostics, Inc. in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% less funds holding

Funds holding: 4336 (-7)

49% less capital invested

Capital invested by funds: $4.58M → $2.33M (-$2.26M)

54% less call options, than puts

Call options by funds: $53K | Put options by funds: $116K

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

71% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 17

Holders
36
Holders Change
-7
Holders Change %
-16.28%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
17
Closed
11
Calls
$53K
Puts
$116K
Net Calls
-$63K
Net Calls Change
+$129K

CEMI Hedge Fund Activity: Q1 2022 in Review

36 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q1 2022, worth a combined $2.33M — down 49% from $4.58M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CEMI and 4 opened new positions — a net loss of 7 holders — while 17 trimmed existing stakes and 5 added.

The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $116K. The largest seller was Vanguard Group, cutting an estimated $281K.

  • 36 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q1 2022, down from 43 in Q4 2021.
  • Funds reported $2.33M of Chembio diagnostics, Inc. stock for Q1 2022, down 49% quarter-over-quarter.
  • 4 funds opened new Chembio diagnostics, Inc. positions in Q1 2022 and 11 closed out, a net change of -7 holders.
  • The largest Chembio diagnostics, Inc. buyer in Q1 2022 was Bank of New York Mellon, an estimated $116K added.
  • The largest Chembio diagnostics, Inc. seller in Q1 2022 was Vanguard Group, an estimated $281K sold.

Based on aggregated 13F filings for Q1 2022.